stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. VTAK
    stockgist
    HomeTop MoversCompaniesConcepts
    VTAK logo

    Catheter Precision, Inc.

    VTAK
    AMEX
    Healthcare
    Medical - Devices
    Fort Mill, SC, US22 employeescatheterprecision.com
    $0.90
    -0.04(-4.06%)

    Mkt Cap $974.4K

    $0.93
    $11.40

    52-Week Range

    At a Glance

    AI-generated

    Persistent operating losses widened to -$17.7M amid R&D investments and impairments, as LockeT sales growth from long-term hospital contracts and sales team expansion provided limited offset while free cash flow burn of -$8.3M signals acute liquidity pressure.

    Revenue breakdown: Product (100%).

    8-K
    Catheter Precision reported 2025 full-year revenue of $819 thousand, up 95% year-over-year, alongside Q4 revenue growth of 60%, and announced post-year-end acquisition of Flyte to diversify into aviation.

    $974.4K

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees22
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Product100%($1M)

    Revenue by Geography

    US75.3%($933.0K)
    Europe24.7%($306.0K)
    Activity

    What Changed Recently

    Financial Results
    Mar 30, 2026

    , including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act o

    Material Agreement
    Jan 7, 2026

    Entry into a Material Definitive Agreement. Second Amendment to Short Term Promissory Notes On December 31, 2025, Catheter Precision, Inc. (the “Company”) amend

    Material Agreement+4 More
    Mar 8, 2026

    , the Company relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder for transact

    Material Agreement+3 More
    Feb 11, 2026

    of this Current Report on From 8-K is hereby incorporated herein by reference. Item 7.01 Regulation FD Disclosure. On February 12, 2026, the Company issued a pr

    Material Agreement+4 More
    Feb 5, 2026

    , the Company relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder for transact

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    HSCSHeartSciences Inc.$2.30-2.54%$5M-0.9
    GLMDGalmed Pharmaceuticals Lt...$0.53-1.89%$3M-0.4
    BBLGBone Biologics Corporatio...$1.23+6.03%$2M-0.4
    UPCUniverse Pharmaceuticals ...$2.80+2.56%$2M-0.4
    NIVFNewGenIvf Group Limited$2.10-2.78%$1M0.1
    TIVCTivic Health Systems, Inc...$0.95-5.45%$1M-0.2
    ISPCiSpecimen Inc.$0.14-6.25%$791.5K-0.1
    ELABPMGC Holdings Inc.$5.50-60.72%$97.2K-0.0
    Analyst View
    Company Profile
    CIK0001716621
    ISINUS74933X7084
    Phone973 691 2000
    Address1670 Highway 160 West, Fort Mill, SC, 29708, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice